Piromelatine

DB12288InvestigationalSmall molecule

Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.

Chemical structure of Piromelatine
Formula / weight
C17H16N2O4 · 312.325 g/mol (avg)
Code names
NEU-P-11

Resolves to

Compound
UNIIS3UN2146K9CAS946846-83-9PubChem24815904
Structure
InChIKeyPNTNBIHOAPJYDB-UHFFFAOYSA-NSMILESCOC1=CC=C2NC=C(CCNC(=O)C3=CC(=O)C=CO3)C2=C1
Targets
P48039MTNR1AP28221HTR1DP08908HTR1A

What you can answer from here — as of April 23, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Piromelatine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In